Weekend reads: Gay canvassing study saga continues; Elsevier policy sparks concern; a string of scandals

booksAs might have been expected, continuing developments in the Michael LaCour gay canvassing study retraction have drowned out coverage of stories that ordinarily might capture a lot of attention, such as fake case reports making their way into CDC data. A sampling:

But just like last week, there was plenty happening elsewhere:


Like Retraction Watch? You can make a tax-deductible contribution to support our work, follow us on X or Bluesky, like us on Facebook, follow us on LinkedIn, add us to your RSS reader, or subscribe to our daily digest. If you find a retraction that’s not in our database, you can let us know here. For comments or feedback, email us at [email protected].


4 thoughts on “Weekend reads: Gay canvassing study saga continues; Elsevier policy sparks concern; a string of scandals”

  1. LaCour is no longer listed on UCLA’s Political Science website over placement candidates:
    http://www.polisci.ucla.edu/graduate/placement-candidates
    I do not know when that happened or what it means, but he was listed there as of March 31, 2015:
    https://web.archive.org/web/20150331073336/http://www.polisci.ucla.edu/graduate/placement-candidates
    “I am equally prepared to teach substantive courses in American politics and public policy as well as quantitative methods and research design courses.” – LaCour. Some statements are interesting also in hindsight.

  2. I’m a bit confused by the Elsevier policy article, which states that they will do green OA with embargo periods of “6 months to 4 years.” In the US, NIH-funded work has to be deposited in PMC within a year. Otherwise, there is the threat of losing NIH eligibility. I haven’t read the policy; maybe it allows for this? Either way, it won’t affect availability of most research in the US, where we have essentially mandatory green OA. If I have to choose between pissing off Elsevier or the NIH, I’m going with Elsevier all the way.

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.